Concepedia

Author

Elsken van der Wall

University Medical Center UtrechtORCID

Also Known As

E VAN DER WALL, E Van Der Wall, E Van der Wall, E van der Wall, E. Van Der Wall, E. Van der Wall, E. Wall, E. van der Wall, E.V.D. Wall, EE Voest

418

Publications

16.4K

Citations

63

H-Index

131

Concepts

All Affiliations

University Medical Center UtrechtUtrecht UniversityThe Netherlands Cancer InstituteAmsterdam UMC Location Vrije Universiteit AmsterdamRadboud University Nijmegen
EV

About

Elsken van der Wall is an author at University Medical Center Utrecht specializing in medicine, breast cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

34

64

3.7K

2

Health Sciences

11

11

945

3

Natural Sciences

5

5

662

4

Engineering

4

4

118

5

Arts

1

1

59

Elsken van der Wall

×

171

Publications

11.2K

Citations

56

H-Index

YearCitations

Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy

Frits S.A.M. van Dam, Willem Boogerd, Sanne B. Schagen,

JNCI Journal of the National Cancer Institute

1998

768

Levels of Hypoxia-Inducible Factor-1  During Breast Carcinogenesis

Reinhard Bos, Haining Zhong, Colleen F. Hanrahan,

JNCI Journal of the National Cancer Institute

2001

588

Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma

Reinhard Bos, Petra van der Groep, Astrid E. Greijer,

Cancer

2003

496

Up‐regulation of gene expression by hypoxia is mediated predominantly by hypoxia‐inducible factor 1 (HIF‐1)

A.E. Greijer, Petra van der Groep, Dirk Kemming,

The Journal of Pathology

2005

448

Biologic Correlates of <sup>18</sup>Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography

Reinhard Bos, Jacobus J. M. van der Hoeven, Elsken van der Wall,

Journal of Clinical Oncology

2002

320

c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer

M M Vleugel, Astrid E. Greijer, Reinhard Bos,

Human Pathology

2006

273

Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Laetitia E. Lamberts, Maximillian Koch, Johannes S. de Jong,

Clinical Cancer Research

2016

267

Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage

Geert van Tetering, Paul van Diest, Ingrid Verlaan,

Journal of Biological Chemistry

2009

265

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

Sjoerd Rodenhuis, Dick J. Richel, Elsken van der Wall,

The Lancet

1998

243

Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial

Noémie Travier, Miranda J. Velthuis, Charlotte N. Steins Bisschop,

BMC Medicine

2015

233

Page 1